Key facts
- It has raised $39.7M across 2 recorded rounds; the latest was Early Stage VC ($18.7M) in Jul 2023.
- Notable investors include Mana Ventures, Liquid 2 Ventures, Evolution VC Partners, City Light Capital, MicroVentures — 24 tracked in total.
- Getlabs has filed 2 Form Ds with the SEC since 2021, most recently Aug 2023 ($18.7M sold to 17 investors).
- Status: Privately Held (backing).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for Getlabs
Create free account
No card required
Funding rounds
2 roundsAbout Getlabs
Developer of a digital health platform designed to enhance patient adherence with at-home diagnostics. The company's platform provides nationwide coverage, enabling healthcare organizations to dispatch medical specialists to patients for diagnostic exam collection.
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Founded
- 2018
- Employees
- 330
- Website
- getlabs.com/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
Getlabs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Getlabs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Getlabs in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.